The ET-1 receptor ETAR shows a pattern similar to that of the ligand, i.e., ETAR expression is elevated in dysplasia and bone metastasis, with a characteristic distribution at the plasma membrane level while being low in primary breast carcinoma. The gene discussed is EDNRA; the disease is breast carcinoma.